Abstract
Brain ischemia resulting from multiple disease states including cardiac arrest, stroke and traumatic brain injury, is a leading cause of death and disability. Despite significant resources dedicated to developing pharmacological interventions, few effective therapeutic options are currently available. The basic consequence of cerebral ischemia, characterized by energy failure and subsequent brain metabolic abnormalities, enables the protective effects by pharmacological manipulation of brain metabolism. We present here the important roles of brain glycogen metabolism and propose inhibition of glycogenolysis as a therapeutic approach to cerebral ischemia.
Keywords: Brain glycogen, cerebral ischemia, glycogenolysis, inhibitors, Brain ischemia, traumatic brain injury, brain glycogen metabolism, Brain, Neurons, glycogen synthase, Astrocytes, neurotransmitters, glycogen phosphorylase, phosphorylase kinase, glucose-6-phosphate, hypoglycemia, oxidative phosphorylation, glutamate mediated excitotox-icity, Glycogen Storage, methinionine sulfoximine, glucose-depleted brain tissue, glutathione system, Glutathione disulfide, Amelioration of Lactic Acidosis, glycolytic pathway, glycolytic substrate, Mitochondria, reactive oxygen species, Maslinic Acid, CP-316819, Magnesium Sulfate, N-methyl-D-aspartate, Uridine diphosphate glucose, uridine triphos-phate, glucose-1-phosphate uridyltrans-ferase, electroencephalogram
Mini-Reviews in Medicinal Chemistry
Title: Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Volume: 10 Issue: 12
Author(s): L. Xu and H. Sun
Affiliation:
Keywords: Brain glycogen, cerebral ischemia, glycogenolysis, inhibitors, Brain ischemia, traumatic brain injury, brain glycogen metabolism, Brain, Neurons, glycogen synthase, Astrocytes, neurotransmitters, glycogen phosphorylase, phosphorylase kinase, glucose-6-phosphate, hypoglycemia, oxidative phosphorylation, glutamate mediated excitotox-icity, Glycogen Storage, methinionine sulfoximine, glucose-depleted brain tissue, glutathione system, Glutathione disulfide, Amelioration of Lactic Acidosis, glycolytic pathway, glycolytic substrate, Mitochondria, reactive oxygen species, Maslinic Acid, CP-316819, Magnesium Sulfate, N-methyl-D-aspartate, Uridine diphosphate glucose, uridine triphos-phate, glucose-1-phosphate uridyltrans-ferase, electroencephalogram
Abstract: Brain ischemia resulting from multiple disease states including cardiac arrest, stroke and traumatic brain injury, is a leading cause of death and disability. Despite significant resources dedicated to developing pharmacological interventions, few effective therapeutic options are currently available. The basic consequence of cerebral ischemia, characterized by energy failure and subsequent brain metabolic abnormalities, enables the protective effects by pharmacological manipulation of brain metabolism. We present here the important roles of brain glycogen metabolism and propose inhibition of glycogenolysis as a therapeutic approach to cerebral ischemia.
Export Options
About this article
Cite this article as:
Xu L. and Sun H., Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia, Mini-Reviews in Medicinal Chemistry 2010; 10 (12) . https://dx.doi.org/10.2174/1389557511009011188
DOI https://dx.doi.org/10.2174/1389557511009011188 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Drugs and mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer’s, Parkinson’s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Measurement of the Endogenous Adenosine Concentration in Humans In Vivo: Methodological Considerations
Current Drug Metabolism Chronic Tobacco Exposure by Smoking Develops Insulin Resistance
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic: Innate Immune Responses in CNS Neurodegenerative Diseases (Guest Editors: Hans van Noort and Sandra Amor)]
CNS & Neurological Disorders - Drug Targets Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data
Current Drug Targets Enlightening the Mechanism of Ferroptosis in Epileptic Heart
Current Medicinal Chemistry Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study
Current Topics in Medicinal Chemistry Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Current Gene Therapy Non Pharmacological Strategies to Promote Spinal Cord Regeneration: A View on Some Individual or Combined Approaches
Current Pharmaceutical Design Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy Inflammation and Immunology of the Vitreoretinal Compartment
Inflammation & Allergy - Drug Targets (Discontinued) Possible Neuroprotective Strategies for Huntingtons Disease
Current Neuropharmacology Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Molecular Imaging in the Default Mode Network
Current Molecular Imaging (Discontinued) Post-cardiac Arrest Syndrome in Children
Current Pediatric Reviews The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Determination of Spatial and Temporal Distribution of Microglia by 230nm-High-Resolution, High-Throughput Automated Analysis Reveals Different Amyloid Plaque Populations in an APP/PS1 Mouse Model of Alzheimers Disease
Current Alzheimer Research NADPH Oxidases and Inflammatory Bowel Disease
Current Medicinal Chemistry Pathophysiology of the Vascular Wall and its Relevance for Cerebrovascular Disorders in Aged Rodents
Current Neurovascular Research Melatonin Metabolism in the Central Nervous System
Current Neuropharmacology